Extracellular Matrix

The extracellular matrix (ECM) is one of the most fundamental structures in animal biology. It fills the space between cells in every tissue and turns isolated cells into functional organs. Far from being a passive scaffold, the ECM actively controls cell behavior, stores biochemical signals and translates mechanical forces into cellular responses.

This dossier is written for readers who want a clear, evidence-based overview of what the ECM is, what it is made of, how it is organized and what it does — with a focus on connective tissue, bone, cartilage, wound healing and fibrosis. It complements the AARO LAB dossiers on fibrosis, Peyronie's disease and Dupuytren's contracture.

• The extracellular matrix (ECM) is the three-dimensional network of proteins, glycoproteins and polysaccharides located outside cells within every tissue.
• It is not a passive scaffold: the ECM stores growth factors, transmits mechanical forces and actively regulates cell behavior.
• Its composition is tissue-specific — the ECM of bone, cartilage, skin, tendon and a basement membrane are very different.
• Major components include collagen, elastin, fibronectin, laminins, proteoglycans, glycosaminoglycans (including hyaluronan) and ground substance.
• Fibroblasts are the main producers in most connective tissues; chondrocytes, osteoblasts, epithelial and endothelial cells produce specialized matrices.
• The ECM is continuously produced and remodeled by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs).
• Excess accumulation or disorganization of the ECM contributes to fibrosis, including in Peyronie's disease and Dupuytren's contracture.

The extracellular matrix, commonly abbreviated as ECM, is a three-dimensional network of proteins, glycoproteins, proteoglycans and other molecules located outside cells within every tissue. It provides structural support, organizes tissues and influences cell behavior through biochemical and mechanical signals.

In animal biology, virtually every cell sits in — or on — an extracellular matrix. In connective tissue, cells are embedded in an abundant fibrillar matrix. In epithelia, cells rest on a thin, specialized sheet of ECM called the basement membrane. Different tissues, from tendon to cartilage to bone, share the same general concept of an ECM but differ dramatically in composition and organization.

The ECM is not a static wall. It is continuously synthesized, secreted, cross-linked and degraded, and its composition changes with development, repair, aging and disease.

The extracellular matrix is located in the extracellular space — between and around cells — in every tissue. Its amount and composition vary from thin basement membranes under epithelia to abundant matrix in cartilage, bone and connective tissue.

• In connective tissue, the ECM is abundant and fills most of the space between cells.
• Under epithelia and endothelia, it forms a thin sheet called the basement membrane.
• In cartilage, it is exceptionally abundant and highly hydrated, providing compression resistance.
• In bone, it is mineralized by hydroxyapatite crystals to combine tensile and compressive strength.
• In many epithelia, the extracellular space is narrow and the ECM is mostly reduced to the basement membrane.

There is therefore no single, uniform extracellular matrix; each tissue has its own version of the ECM, adapted to its function.

The extracellular matrix of connective tissue is composed of fibrillar proteins (mainly collagen and elastin), adhesive glycoproteins (fibronectin, laminins), proteoglycans, glycosaminoglycans (including hyaluronan) and a ground substance of water and ions. Composition varies by tissue.

Components can be grouped into four functional families:

1. Fibrous proteins — collagen (tensile strength) and elastin (elastic recoil).
2. Adhesive glycoproteins — fibronectin and laminins, which anchor cells to the matrix through integrins.
3. Proteoglycans and glycosaminoglycans — including aggrecan, decorin, versican, hyaluronan, chondroitin sulfate, heparan sulfate and dermatan sulfate.
4. Ground substance — the hydrated amorphous component that fills the space between fibers and cells.

Table 1 — Major ECM components.

Ground substance is a component of the extracellular matrix, not a synonym for it. The full ECM also includes fibrous elements such as collagen and elastin fibers, which the ground substance surrounds.

Collagen

Collagen is the most abundant protein in the human body and the dominant ECM component. Fibrillar collagens (types I, II, III, V, XI) assemble into robust fibrils that provide tensile strength. Network collagens (type IV, VIII) form sheet-like structures in basement membranes. Type I collagen dominates skin, tendon and bone; type II collagen dominates cartilage; type IV collagen defines the basement membrane.

Elastin

Elastin, cross-linked by desmosine and isodesmosine, gives tissues the ability to stretch and recoil. It is abundant in the aorta, lung, skin and elastic ligaments.

Fibronectin

Fibronectin is a large adhesive glycoprotein that bridges collagen, proteoglycans and integrins on the cell surface. It plays a central role in cell adhesion, migration and wound healing.

Laminins

Laminins are cross-shaped glycoproteins that are essential constituents of basement membranes. They provide anchoring points for epithelial and endothelial cells and are required for tissue organization during development.

Proteoglycans

Proteoglycans consist of a core protein decorated with long glycosaminoglycan chains. They regulate hydration, compression resistance and the binding of growth factors. Aggrecan is prominent in cartilage, perlecan in basement membranes, decorin and versican in connective tissue.

Glycosaminoglycans

Glycosaminoglycans (GAGs) are long, negatively charged polysaccharides that retain water and ions. Hyaluronan is unique among GAGs in that it is not sulfated and not covalently linked to a protein core; it is especially abundant in cartilage, skin and the vitreous body. Chondroitin sulfate, heparan sulfate and dermatan sulfate are sulfated GAGs bound to proteoglycans.

Ground substance

Ground substance is the amorphous, hydrated part of the ECM that surrounds fibrous elements. It is dominated by GAGs, proteoglycans and interstitial fluid, and enables the diffusion of nutrients, gases and signaling molecules between capillaries and cells.

The extracellular matrix is not identical in every tissue. Its structural organization ranges from thin, sheet-like basement membranes to bulky, three-dimensional interstitial matrices and to highly specialized mineralized matrices in bone and cartilage.

Table 2 — Interstitial matrix versus basement membrane and other specialized matrices.

The extracellular matrix provides mechanical support, anchors cells, transmits and interprets forces, stores growth factors, and guides cell migration, differentiation and tissue organization. It is a dynamic biochemical and mechanical environment, not just a scaffold.

Table 3 — ECM functions with mechanisms and examples.

Connective tissues contain the largest fraction of extracellular matrix in the body. Cells such as fibroblasts are embedded in an abundant interstitial matrix made of fibrillar collagens, elastin, proteoglycans and hyaluronan.

The composition of the ECM in connective tissue depends on the function of the tissue: dense fibrous tissue in tendon and ligament emphasizes fibrillar collagen alignment, whereas loose connective tissue includes more ground substance and elastin. Connective tissue is not reducible to its matrix, however — it also contains cells, blood vessels and nerves.

Bone contains a specialized mineralized ECM. Its organic phase is dominated by type I collagen, and its inorganic phase consists of hydroxyapatite crystals of calcium phosphate. This combination provides bone with both tensile resistance (from collagen) and compressive resistance (from mineral).

Osteoblasts produce and mineralize the organic matrix; osteocytes embedded in bone continuously sense and maintain it; osteoclasts resorb the matrix during remodeling.

Cartilage is one of the most matrix-rich tissues in the body. Its ECM consists mainly of type II collagen and highly hydrated proteoglycans such as aggrecan, giving it exceptional compression resistance.

The chondrocyte is the only cell type in mature cartilage, and it is embedded in an abundant matrix. Cartilage is largely avascular, which limits its capacity for repair — most cartilage injuries do not fully heal.

A basement membrane is a thin, specialized sheet of ECM located under every epithelium and endothelium. It is composed mainly of type IV collagen, laminins, nidogen and perlecan.

Basement membranes anchor epithelial and endothelial cells, maintain cell polarity, act as filtration barriers (as in the renal glomerulus) and define compartments within tissues.

The interstitial matrix is the portion of the ECM located between cells in connective tissue. It contains fibrillar collagens I and III, elastin, fibronectin, proteoglycans and hyaluronan, and provides bulk mechanical support and tissue organization.

The interstitial matrix is the main site of pathological remodeling in most fibrotic diseases.

The extracellular matrix is produced by cells that synthesize its components inside the endoplasmic reticulum, secrete them into the extracellular space, and assemble them into fibers and networks that are then stabilized by cross-linking enzymes.

The main producing cells are:

• Fibroblasts in most connective tissues.
• Myofibroblasts during wound healing and in fibrosis.
• Chondrocytes in cartilage.
• Osteoblasts in bone.
• Epithelial cells for their basement membranes.
• Endothelial cells for the basement membrane of blood vessels.

Fibroblasts are the workhorse cells of ECM production in connective tissue. They synthesize collagen, elastin, proteoglycans and adhesive glycoproteins, and continuously adapt matrix composition to mechanical and biochemical cues.

Under injury or persistent TGF-β signaling, fibroblasts differentiate into contractile myofibroblasts, which massively increase collagen production. In normal wound healing, myofibroblasts disappear after repair. Their persistence is a hallmark of fibrosis.

ECM remodeling is the continuous cycle of synthesis, degradation and reassembly of matrix components that adapts tissue architecture to physiological demands, growth, exercise and repair. It involves fibroblasts, MMPs, TIMPs and cross-linking enzymes such as lysyl oxidase (LOX).

Physiological remodeling maintains tissue homeostasis. Pathological remodeling — with either excess degradation or excess deposition — leads to tissue destruction (e.g. emphysema) or fibrosis.

Matrix metalloproteinases are a family of zinc-dependent enzymes that degrade specific ECM components. Collagenases (MMP-1, -8, -13) cleave fibrillar collagens; gelatinases (MMP-2, -9) degrade denatured collagen and basement membranes; stromelysins (MMP-3, -10, -11) act on proteoglycans and other substrates.

MMPs are essential for physiological remodeling and wound healing, but chronic dysregulation contributes to fibrosis, arthritis and cancer invasion.

TIMPs are the main endogenous inhibitors of MMPs. Four members (TIMP-1 to TIMP-4) balance MMP activity so that matrix degradation remains proportionate to synthesis.

The MMP/TIMP balance is a key determinant of tissue outcome. A shift toward TIMPs favors matrix accumulation and fibrosis; a shift toward MMPs favors matrix loss and structural weakening.

Even in mature tissues, the extracellular matrix is not static. Collagen half-life in most tissues is measured in months to years, and every ECM component is continuously replaced. This turnover allows the matrix to adapt to load, injury and aging.

Blood biomarkers of collagen turnover — such as pro-collagen fragments (e.g. PRO-C3, C3M) — are increasingly used in research to monitor ECM remodeling non-invasively.

Wound healing depends on precise, temporally regulated ECM changes. A provisional matrix of fibrin and fibronectin is laid down first, fibroblasts and myofibroblasts then deposit collagen, and the immature scar is progressively remodeled into mature tissue.

When this program is repeatedly triggered or fails to terminate, normal healing tips over into fibrosis. See the dossier on normal wound healing for the detailed physiological sequence.

Fibrosis is not simply "too much collagen". It involves excessive deposition, altered composition and organization, increased cross-linking, reduced degradation, and abnormal mechanical properties of the ECM, all sustained by persistent fibroblast and myofibroblast activation.

Table 4 — Healthy versus fibrotic ECM.

For a comprehensive review of fibrotic diseases across organs, see the dossier on fibrosis.

Matrix stiffness — the mechanical resistance of the ECM to deformation — is a critical biological signal. Cells sense matrix stiffness through integrins and focal adhesions and adapt their behavior accordingly.

A stiff, cross-linked matrix promotes fibroblast activation and myofibroblast persistence, creating a self-reinforcing loop that sustains fibrosis. Conversely, an appropriately compliant matrix supports normal cell function.

Mechanotransduction is the process by which cells convert mechanical signals from the ECM into biochemical responses. Integrins, focal adhesions and downstream mediators such as YAP/TAZ translate matrix stiffness and tension into changes in gene expression.

Mechanotransduction couples ECM biology to cell differentiation, proliferation and survival, and it is a central driver of the fibrotic response to a stiff matrix.

In Peyronie's disease, fibrotic remodeling of the ECM affects mainly the tunica albuginea of the penis. Excess type I collagen and disorganized fibers form a palpable plaque that alters penile geometry during erection.

The disease is driven by TGF-β1, myofibroblast activation and impaired MMP-mediated remodeling. See the dedicated dossier on Peyronie's disease.

In Dupuytren's contracture, abnormal ECM remodeling affects the palmar aponeurosis. Fibroblasts and myofibroblasts deposit collagen-rich nodules and cords that progressively contract and flex the fingers.

Although both diseases involve fibrotic ECM remodeling, their anatomy and consequences differ. See the dossier on Dupuytren's contracture for the clinical detail.

Research on the extracellular matrix is expanding rapidly, driven by omics technologies, imaging and mechanobiology. Below are some of the most active directions.

• Matrisome cartography

  Comprehensive catalog of the ~1,000 genes coding for ECM components and regulators (Hynes & Naba).

• Matrix stiffness and cell fate

  How matrix mechanics drive stem cell differentiation, cancer invasion and fibroblast activation via YAP/TAZ.

• Anti-fibrotic drugs targeting the ECM

  Small molecules against lysyl oxidase (LOX), collagen synthesis or TGF-β signaling.

• Matrix-derived blood biomarkers

  Collagen turnover peptides (PRO-C3, C3M) as surrogates of tissue remodeling.

• Decellularized matrix scaffolds

  Tissue engineering using native ECM as a template for regenerative medicine.

• Matrikines and signaling fragments

  Bioactive ECM-derived peptides such as endostatin, tumstatin and elastin-derived peptides.

Table 5 — Extracellular matrix versus ground substance.

A selection of reference publications used to write this dossier. Titles are kept in their original English wording.